2006
DOI: 10.1016/j.febslet.2006.07.071
|View full text |Cite
|
Sign up to set email alerts
|

New insights on the use of desipramine as an inhibitor for acid ceramidase

Abstract: Treatment of different cancer cell lines with desipramine induced a time-and dose-dependent downregulation of acid ceramidase. Desipramine's effect on acid ceramidase appeared specific for amphiphilic agents (desipramine, chlorpromazine, and chloroquine) but not other lysomotropic agents such as ammonium chloride and bafilomycin A1, and was not transcriptionally regulated. The cathepsin B/L inhibitor, CA074ME, but not the cathepsin D inhibitor, pepstatin A, blocked desipramine's effect on acid ceramidase. Desi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
90
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 102 publications
(98 citation statements)
references
References 20 publications
7
90
1
Order By: Relevance
“…This finding is reminiscent of the involvement of cathepsins B and L in the aCDase degradation induced by chemical treatments, such as desipramine, chloroquine, or chlorpromazine (27).…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…This finding is reminiscent of the involvement of cathepsins B and L in the aCDase degradation induced by chemical treatments, such as desipramine, chloroquine, or chlorpromazine (27).…”
Section: Discussionmentioning
confidence: 90%
“…3A). Cathepsin B is a lysosomal cysteine protease that has been shown to be implicated in aCDase degradation after treatment with desipramine (27). Thus, this enzyme was tested as a possible cause for aCDase degradation.…”
Section: Dacarbazine Treatment Of Melanoma Cellsmentioning
confidence: 99%
“…Their organic ring integrates into the inner lysosomal membrane, and the tertiary amino group displaces acid sphingomyelinase from the membrane; this displacement results in proteolytic degradation of acid sphingomyelinase in the lysosome (Hurwitz et al, 1994;Kornhuber et al, 2008). These drugs also induce degradation of the acid ceramidase in vitro (Elojeimy et al, 2006), although this effect seems to absent in vivo (Gulbins et al, 2013) Theoretically, the drugs should interfere with many proteins binding to the inner leaflet of the lysosomal membrane, but at present potential off-targets are not characterized yet.…”
Section: Ceramide In Cystic Fibrosismentioning
confidence: 99%
“…Desipramine, therefore, would be expected to decrease levels of sphingosine and sphingosine1-phosphate, and to increase ceramide concentrations. Feeding of animal cell lines with desipramine indeed resulted in ceramide accumulation, from a desipramine concentration of 5 μM [32]. Desipramine also inhibits the conversion of sphingosines to sphingomyelins (catalysed by sphingomyelin synthase), a reaction found in animals, not in plants [16].…”
Section: Effects Of Inhibitors Of Sphingolipid Biosynthesismentioning
confidence: 99%